Phenotypic manifestations of the OCTN2 V295X mutation: Sudden infant death and carnitine‐responsive cardiomyopathy in Roma families

No abstract is available for this paper.

• Publication year

  2004

• Venue

  American Journal of Medical Genetics. Part A

• Publication date

  2004-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ajmg.a.30207PMID 15487009
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel mRNA molecules are induced in hypertrophied ventricles of carnitine-deficient mice and belong to a family of up-regulated gene in cells overexpressing c-erbB-2.

  2002cited by this paper
• Novel mRNA molecules are induced in hypertrophied ventricles of carnitine-deficient mice and belong to a family of up-regulated gene in cells overexpressing c-erbB-2

  2002cited by this paper
• Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy.

  2002influential reference
• A founder mutation (R254X) of SLC22A5 (OCTN2) in Chinese primary carnitine deficiency patients

  2002cited by this paper
• Carnitine membrane transporter deficiency: a long-term follow up and OCTN2 mutation in the first documented case of primary carnitine deficiency.

  2002cited by this paper
• Identification of two novel mutations in OCTN2 from two Saudi patients with systemic carnitine deficiency

  2002cited by this paper
• Genetic studies of the Roma (Gypsies): a review

  2001cited by this paper
• Patterns of inter- and intra-group genetic diversity in the Vlax Roma as revealed by Y chromosome and mitochondrial DNA lineages

  2001cited by this paper
• Phenotype and genotype variation in primary carnitine deficiency

  2001influential reference
• Origins and divergence of the Roma (gypsies).

  2001cited by this paper
• An improved method for DNA extraction from paraffin sections.

  2001cited by this paper
• Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency

  2000cited by this paper
• A missense mutation in the OCTN2 gene associated with residual carnitine transport activity

  2000cited by this paper
• Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: Lack of genotype–phenotype correlation

  2000cited by this paper
• Identification of two novel mutations in OCTN2 of three patients with systemic carnitine deficiency

  1999influential reference
• Carnitine transporter OCTN2 mutations in systemic primary carnitine deficiency: a novel Arg169Gln mutation and a recurrent Arg282ter mutation associated with an unconventional splicing abnormality.

  1999influential reference
• Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency.

  1999cited by this paper
• Mutations of OCTN2, an organic cation/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency.

  1999cited by this paper
• Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency.

  1999cited by this paper
• Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter

  1999influential reference
• Molecular and Functional Identification of Sodium Ion-dependent, High Affinity Human Carnitine Transporter OCTN2*

  1998cited by this paper
• Carnitine uptake defect: frameshift mutations in the human plasmalemmal carnitine transporter gene.

  1998cited by this paper
• cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family.

  1998cited by this paper
• Carnitine administration ameliorates the changes in energy metabolism caused by short-term pivampicillin medication

  1997cited by this paper
• Sudden neonatal death in carnitine transporter deficiency.

  1997cited by this paper
• Metabolic disease and sudden, unexpected death in infancy.

  1994cited by this paper
• Preferential elimination of pivalate with supplemental carnitine via formation of pivaloylcarnitine in man.

  1993cited by this paper
• Differential excretion of xenobiotic acyl-esters of carnitine due to administration of pivampicillin and valproate.

  1990cited by this paper
• Sudden infant death syndrome and inherited disorders of fatty acid beta-oxidation.

  1990cited by this paper
• Pivampicillin-promoted excretion of pivaloylcarnitine in humans.

  1987cited by this paper
• Carnitine deficiency, organic acidemias, and Reye's syndrome

  1985cited by this paper

• Clinical characteristics of primary carnitine deficiency: A structured review using a case‐by‐case approach

  2022cites this paper
• Primary carnitine deficiency is a life‐long disease

  2022cites this paper
• Targeted Therapies for Metabolic Myopathies Related to Glycogen Storage and Lipid Metabolism: a Systematic Review and Steps Towards a ‘Treatabolome’

  2021cites this paper
• Mass Spectrometric Analysis of L-carnitine and its Esters: Potential Biomarkers of Disturbances in Carnitine Homeostasis

  2019cites this paper
• The decision to discontinue screening for carnitine uptake disorder in New Zealand

  2018cites this paper
• Congenital and Acquired Heart Disease

  2017cites this paper
• Expression von Aufnahme-Transportern für Zytostatika in Mamma- und Prostatakarzinom-Zellen und ihre Interaktion mit Zytostatika

  2017cites this paper
• Fuel availability and fate in cardiac metabolism: A tale of two substrates.

  2016cites this paper
• Identification of SLC22A5 Gene Mutation in a Family with Carnitine Uptake Defect

  2015cites this paper
• Disappearance of left ventricular hypertrabeculation/noncompaction in vacuolar non-neuromuscular cardiomyopathy.

  2015cites this paper
• MARVELD2 (DFNB49) Mutations in the Hearing Impaired Central European Roma Population - Prevalence, Clinical Impact and the Common Origin

  2015cites this paper
• Primary Carnitine deficiency in the Faroe Islands: health and cardiac status in 76 adult patients diagnosed by screening

  2014cites this paper
• Post-Genomic Analysis of Fatty Acid and Glucose Metabolism in Cardiovascular Disease

  2014cites this paper
• The Role of Clinical Observation: Red Flag 7 — Syndromic and Multi-system Cardiomyopathies

  2013cites this paper
• Mitochondria in Pediatric Cardiovascular Diseases

  2013cites this paper
• OCTN Cation Transporters in Health and Disease

  2013cites this paper
• Roma (Gypsies): Genetic Studies

  2013cites this paper
• Expanded newborn screening for inborn errors of metabolism: overview and outcomes.

  2012cites this paper
• Strategies of Bacterial Over Expression of Membrane Transporters Relevant in Human Health: The Successful Case of the Three Members of OCTN Subfamily

  2012cites this paper
• Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders

  2012cites this paper
• Identification of mutations and evaluation of cardiomyopathy in Turkish patients with primary carnitine deficiency.

  2012cites this paper
• Mouse Cardiac Acyl Coenzyme A Synthetase 1 Deficiency Impairs Fatty Acid Oxidation and Induces Cardiac Hypertrophy

  2011cites this paper
• Gene variants predisposing to SIDS: current knowledge

  2011cites this paper
• Károly Méhes: Pioneer in the study of minor anomalies. A good and creative friend remembered

  2010cites this paper
• Mort subite et complexes moléculaires des canaux ioniques cardiaques

  2010cites this paper
• Population Pharmacogenomics and Personalized Medicine Research in Hungary: Achievements and Lessons Learned

  2010cites this paper
• Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation

  2010cites this paper
• Molecular spectrum of SLC22A5 (OCTN2) gene mutations detected in 143 subjects evaluated for systemic carnitine deficiency

  2010cites this paper
• GENETIC VARIABILITY AND INTERETHNIC DIFFERENCES OF SELECTED PHARMACOGENETICALLY RELEVANT GENES IN AVERAGE HUNGARIAN AND ROMA POPULATION SAMPLES Doctoral (Ph.D.) thesis

  2010cites this paper
• End-Stage Cardiac Disease as an Initial Presentation of Systemic Myopathies: Case Series and Literature Review

  2010cites this paper
• GENETIC VARIABILITY AND INTERETHNIC DIFFERENCES OF SELECTED PHARMACOGENETICALLY RELEVANT GENES IN AVERAGE HUNGARIAN AND

  2010cites this paper
• Syndrome of allergy, apraxia, and malabsorption: characterization of a neurodevelopmental phenotype that responds to omega 3 and vitamin E supplementation.

  2009cites this paper
• Plasma carnitine ester profile in homozygous and heterozygous OCTN2 deficiency

  2009cites this paper
• The mechanism of dead-in-bed syndrome and other sudden unexplained nocturnal deaths.

  2009cites this paper
• CHAPTER 16 – Fatty Acid and Glucose Metabolism in Cardiac Disease

  2007cites this paper
• Liver Disease in Children: Inborn Errors of Mitochondrial Fatty Acid Oxidation

  2007cites this paper
• Histopathologic abnormalities of the lymphoreticular tissues in organic cation transporter 2 deficiency: evidence for impaired B cell maturation.

  2007cites this paper
• Exclusive cardiac dysfunction in familial primary carnitine deficiency cases: a genotype–phenotype correlation

  2007cites this paper
• Combined therapy with PPARalpha agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency.

  2006cites this paper
• Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency.

  2005cites this paper